Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Compound Genetics is a premier cannabis genetics and biotechnology company focused on the development of elite cultivars with unique chemical and terpene profiles. Founded in 2017 and based in San Francisco, the company utilizes advanced breeding techniques, including genomic selection and tissue culture, to create proprietary strains for the global medicinal and recreational markets. Their portfolio features high-profile genetics such as Jet Fuel Gelato, Apples and Bananas, and Pavé, which are licensed to leading cultivators worldwide. In early 2024, Compound Genetics was acquired by Sunderstorm, a prominent cannabis consumer products company, to integrate its extensive genetic library into a diverse range of consumer goods. The company continues to operate as a center for genetic innovation, emphasizing plant vigor and phytochemical diversity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Compound Genetics.